| A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E) JPT Higgins, RL Morgan, AA Rooney, KW Taylor, KA Thayer, RA Silva, ... Environment international 186, 108602, 2024 | 14 | 2024 |
| Assessing risk of bias in a non‐randomized study JAC Sterne, MA Hernán, A McAleenan, BC Reeves, JPT Higgins Cochrane handbook for systematic reviews of interventions, 621-641, 2019 | 471 | 2019 |
| Cost-Effectiveness Analysis of Screening Strategies for Atrial Fibrillation in England and Wales H Thom, W Hollingworth, A McAleenan, P Davies, J Higgins, GN Okoli, ... Value in Health 19 (7), A706-A707, 2016 | | 2016 |
| Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta‐analysis based on a Cochrane systematic review S Brandner, A McAleenan, HE Jones, A Kernohan, T Robinson, L Schmidt, ... Neuropathology and applied neurobiology 48 (4), e12790, 2022 | 17 | 2022 |
| Diagnostic test accuracy and cost‐effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma A McAleenan, HE Jones, A Kernohan, T Robinson, L Schmidt, S Dawson, ... Cochrane Database of Systematic Reviews, 2022 | 13 | 2022 |
| DNA damage provokes cohesin sumoylation in Saccharomyces cerevisiae ASJ McAleenan Imperial College London, 2010 | | 2010 |
| Does testosterone mediate the relationship between vitamin D and prostate cancer progression? A systematic review and meta-analysis LA Robles, S Harrison, VY Tan, R Beynon, A McAleenan, JPT Higgins, ... Cancer Causes & Control 33 (8), 1025-1038, 2022 | 8 | 2022 |
| Effectiveness of BRAF inhibitors in patients with BRAF V600 mutation positive glioma: a systematic review I Yao, S Dawson, J Higgins, L McGuinness, A McAleenan, KM Kurian Neuro-Oncology 21 (Suppl 4), iv14, 2019 | | 2019 |
| Evidence of ribavirin treatment for Lassa fever: a systematic review of published and unpublished studies HY Cheng, C French, A Salam, S Dawson, A McAleenan, J Savovic, ... Evidence of ribavirin treatment for Lassa fever: a systematic review of …, 2021 | 2 | 2021 |
| Increased Secretion of Lipoproteins in Transgenic Mice Expressing Human D374Y PCSK9 Under Physiological Genetic Control B Herbert, D Patel, SN Waddington, ER Eden, A McAleenan, XM Sun, ... Arteriosclerosis, thrombosis, and vascular biology 30 (7), 1333-1339, 2010 | 88 | 2010 |
| Lack of evidence for ribavirin treatment of Lassa fever in systematic review of published and unpublished studies HY Cheng, CE French, AP Salam, S Dawson, A McAleenan, ... Emerging Infectious Diseases 28 (8), 1559, 2022 | 19 | 2022 |
| Methodological features of clinical pharmacokinetic–pharmacodynamic studies of antibacterials and antifungals: a systematic review A McAleenan, PG Ambrose, SM Bhavnani, GL Drusano, WW Hope, ... Journal of Antimicrobial Chemotherapy 75 (6), 1374-1389, 2020 | 25 | 2020 |
| Methods for the economic evaluation of atrial fibrillation screening NJ Welton, A McAleenan, HHZ Thom, P Davies, W Hollingworth, ... Screening strategies for atrial fibrillation: a systematic review and cost …, 2017 | | 2017 |
| MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a … S Brandner, A McAleenan, C Kelly, F Spiga, HY Cheng, S Dawson, ... Neuro-oncology 23 (9), 1457-1469, 2021 | 49 | 2021 |
| Optimising the design and analysis of clinical trials for antibiotics MEA de Kraker, H Sommer, F de Velde, I Gravestock, E Weiss, ... Dosing Optimization of Beta-Lactam Antibiotics using Parametric and …, 2020 | | 2020 |
| Optimizing the design and analysis of clinical trials for antibacterials against multidrug-resistant organisms: a white paper from COMBACTE’s STAT-Net MEA de Kraker, H Sommer, F de Velde, I Gravestock, E Weiss, ... Clinical Infectious Diseases 67 (12), 1922-1931, 2018 | 34 | 2018 |
| Post-replicative repair involves separase-dependent removal of the kleisin subunit of cohesin A McAleenan, A Clemente-Blanco, V Cordon-Preciado, N Sen, M Esteras, ... Nature 493 (7431), 250-254, 2013 | 68 | 2013 |
| Pre‐emptive versus non pre‐emptive kidney transplantation for end‐stage kidney disease C Van de Bruaene, L Weynants, E Nagler, A McAleenan, R Elbers, ... The Cochrane Database of Systematic Reviews 2018 (12), 2018 | | 2018 |
| Pre‐emptive versus non pre‐emptive kidney transplantation for end‐stage kidney disease CO Parra, C Van de Bruaene, L Weynants, EV Nagler, A McAleenan, ... The Cochrane Database of Systematic Reviews 2018 (12), 2018 | 3 | 2018 |
| Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review LJ Andrews, ZA Thornton, SS Saincher, IY Yao, S Dawson, ... Neuro-oncology 24 (4), 528-540, 2022 | 39 | 2022 |
